Beyond affecting a person’s ability to move normally, Parkinson’s disease can trigger neurobehavioral symptoms. Depression, cognition, and behavioral changes may develop as Parkinson’s disease progresses. Meridian is conducting a clinical trial for an investigational medication being studied for potential effects on behavioral symptoms in people with Parkinson’s disease.
- Must be age 50 to 85
- Must be diagnosed with Parkinson’s disease
- Must have neuropsychiatric symptoms (e.g., delusions (false or mistaken beliefs), hallucinations (seeing or hearing things that aren’t really there), depression, apathy) severe enough to warrant treatment with an antipsychotic agent
- May receive compensation for time and travel
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Meridian Clinical Research
6602 Waters Avenue, Building C
Savannah, GA 31406
Sign up for more information...
About Meridian Clinical Research
Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.